These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26799505)

  • 41. Ultrasound mediated transdermal drug delivery.
    Azagury A; Khoury L; Enden G; Kost J
    Adv Drug Deliv Rev; 2014 Jun; 72():127-43. PubMed ID: 24463344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Traversing the Skin Barrier with Nano-emulsions.
    Burger C; Shahzad Y; Brummer A; Gerber M; du Plessis J
    Curr Drug Deliv; 2017; 14(4):458-472. PubMed ID: 27557672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transdermal drug delivery systems: skin perturbation devices.
    Brown MB; Traynor MJ; Martin GP; Akomeah FK
    Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of transdermal drug delivery via synergistic action of chemicals.
    Karande P; Mitragotri S
    Biochim Biophys Acta; 2009 Nov; 1788(11):2362-73. PubMed ID: 19733150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcutaneous drug delivery: a practical review.
    Berti JJ; Lipsky JJ
    Mayo Clin Proc; 1995 Jun; 70(6):581-6. PubMed ID: 7776720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural products as potential drug permeation enhancer in transdermal drug delivery system.
    Patil UK; Saraogi R
    Arch Dermatol Res; 2014 Jul; 306(5):419-26. PubMed ID: 24481830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
    Alexander A; Dwivedi S; Ajazuddin ; Giri TK; Saraf S; Saraf S; Tripathi DK
    J Control Release; 2012 Nov; 164(1):26-40. PubMed ID: 23064010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting.
    Palmer BC; DeLouise LA
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27983701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of surfactant concentration on transdermal lidocaine delivery with linker microemulsions.
    Yuan JS; Yip A; Nguyen N; Chu J; Wen XY; Acosta EJ
    Int J Pharm; 2010 Jun; 392(1-2):274-84. PubMed ID: 20363304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potentials of new nanocarriers for dermal and transdermal drug delivery.
    Neubert RH
    Eur J Pharm Biopharm; 2011 Jan; 77(1):1-2. PubMed ID: 21111043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug delivery.
    Wong TW
    J Control Release; 2014 Nov; 193():257-69. PubMed ID: 24801250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transdermal microemulsions of Boswellia carterii Bird: formulation, characterization and in vivo evaluation of anti-inflammatory activity.
    Mostafa DM; Ammar NM; Basha M; Hussein RA; El Awdan S; Awad G
    Drug Deliv; 2015; 22(6):748-56. PubMed ID: 24725029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
    Godin B; Touitou E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Azone analogues: classification, design, and transdermal penetration principles.
    Jampilek J; Brychtova K
    Med Res Rev; 2012 Sep; 32(5):907-47. PubMed ID: 22886628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ropivacaine loaded microemulsion and microemulsion-based gel for transdermal delivery: preparation, optimization, and evaluation.
    Zhao L; Wang Y; Zhai Y; Wang Z; Liu J; Zhai G
    Int J Pharm; 2014 Dec; 477(1-2):47-56. PubMed ID: 25304092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electroporation as an efficient physical enhancer for skin drug delivery.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Revilla-Vázquez AL
    J Clin Pharmacol; 2009 Nov; 49(11):1262-83. PubMed ID: 19717723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dermal peptide delivery using enhancer molecules and colloidal carrier systems--part I: carnosine.
    Goebel AS; Schmaus G; Neubert RH; Wohlrab J
    Skin Pharmacol Physiol; 2012; 25(6):281-7. PubMed ID: 22890441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using the method of homogenization to calculate the effective diffusivity of the stratum corneum with permeable corneocytes.
    Rim JE; Pinsky PM; van Osdol WW
    J Biomech; 2008; 41(4):788-96. PubMed ID: 18093598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.